Life-threatening asthma attack during prolonged fingolimod treatment: case report

2014 
Background Fingolimod (FTY) mediates bronchoconstriction by interacting with sphingosine-1-phosphate receptors. The majority of the reported adverse respiratory events occur during the first weeks of treatment.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    6
    References
    5
    Citations
    NaN
    KQI
    []